Cephalic Phase Responses to Nutritive & Non-Nutritive Sweeteners

Status Active, not recruiting

Clinical Trial Summary

This study will focus on changes in blood sugar in response to tasting different types of sweeteners using continuous glucose monitoring (CGM) technology.

Clinical Trial Description

Participants will be recruited through posting of advertisements about the study. Flyers will be posted on and off campus. Individuals interested in the study will contact the researchers and an initial appointment will be scheduled. First Lab Visit (Day 1): Consent and Instruction: Researchers will explain the study procedures, including the use of continuous glucose monitoring (CGM), home-based taste testing and wearing the Fitbit activity tracker. Participants will complete a short questionnaire (screening questionnaire) that elicits demographic, health and activity information. Participants can choose to decline to answer any questions they prefer not to answer. Researchers will determine if participants meet eligibility criteria and participants will then decide if they want to participate. A CGM device will be placed on the participant's arm to monitor glucose levels continuously. Placing the monitor involves putting an egg-shaped plastic container (about the size of a golf ball) on the back of one arm and a button is pushed and this presses the sensor on the arm. It is held on by adhesive. It is like applying a band aid though there is a hair-like flexible fiber that is pressed into the skin (not into a vein). The participant feels little more than mild pressure - far less than a needle stick. Participants will be given individually portioned, labeled sample solutions including a nutritive sweetener, non-nutritive sweetener, a non-sweet control stimulus (salt) and just water along with commercially available no sodium rice cakes (cut to bite-size pieces). Participants will be instructed to place one rice cake sample in their mouth and sip a 5ml oral solution sample and masticate for 15 seconds and expectorate. This will be repeated 3 additional times. With about 15 seconds between samples. This exposure will require about 2 minutes. This will be repeated 4 times a day (before breakfast, before lunch, before dinner and at 8PM) on 8 days. There will be no oral stimulation for 2 days. Participants will be provided with activity recall sheets and instructed to record their sleep patterns, and physical activity for 10 days. This form will only contain an identification code, no personally identifiable information be on the form. Participants will also be asked to wear a Fitbit to monitor activity. This is exactly like wearing a wristwatch. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06387316
Study type	Interventional
Source	Purdue University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 26, 2024
Completion date	March 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05052918` - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes	N/A
Completed	`NCT03714646` - Beta Glucan and Acetate Production	N/A
Completed	`NCT03377244` - Healthy Body Healthy Souls in the Marshallese Population	N/A
Completed	`NCT04427982` - Dance and Diabetes/Prediabetes Self-Management	N/A
Recruiting	`NCT05008276` - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed	`NCT03480022` - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS	Phase 3
Active, not recruiting	`NCT05290233` - Time Restricted Eating Plus Exercise for Weight Management	N/A
Withdrawn	`NCT05726409` - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes	N/A
Completed	`NCT02834078` - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome	N/A
Completed	`NCT04902326` - Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)	N/A
Recruiting	`NCT04168372` - Fructose: Substrate, Stimulus, or Both?	N/A
Completed	`NCT03272074` - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes	N/A
Not yet recruiting	`NCT05939349` - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes	N/A
Completed	`NCT04978376` - TRE With Physical Activity for Weight Management	N/A
Recruiting	`NCT03997656` - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia	N/A
Recruiting	`NCT05166785` - BRInging the Diabetes Prevention Program to GEriatric Populations	N/A
Completed	`NCT01729078` - Dietary Interventions in Prediabetes	N/A
Completed	`NCT04507685` - Asian Indian Prediabetes Study	N/A
Completed	`NCT03292315` - Once Weekly GLP-1 in Persons With Spinal Cord Injury	Phase 4
Active, not recruiting	`NCT05353790` - Dietary Exchanges With Avocado and Mango in Pre-diabetes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Cephalic Phase Responses to Nutritive and Non-Nutritive Sweeteners

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms